3/A

OWNERSHIP DOCUMENT

Company: Apogee Therapeutics, Inc.
Filed: July 17, 2023
Period of Report: July 13, 2023
Accession Number: 0001104659-23-081679

View Document ↗ View on SEC.gov ↗